Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Individuals with germline mutations in the tumor suppressor gene phosphatase and tensin homolog (PTEN), irrespective of clinical presentation, are diagnosed with PTEN hamartoma tumor syndrome (PHTS). PHTS confers a high risk of breast, thyroid, and other cancers or autism spectrum disorder (ASD) with macrocephaly. It remains unclear why mutations in one gene can lead to seemingly disparate phenotypes. Thus, we sought to identify differences in ASD vs. cancer-associated germline PTEN missense mutations by investigating putative structural effects induced by each mutation. We utilized a theoretical computational approach combining in silico structural analysis and molecular dynamics (MD) to interrogate 17 selected mutations from our patient population: six mutations were observed in patients with ASD (only), six mutations in patients with PHTS-associated cancer (only), four mutations shared across both phenotypes, and one mutation with both ASD and cancer. We demonstrate structural stability changes where all six cancer-associated mutations showed a global decrease in structural stability and increased dynamics across the domain interface with a proclivity to unfold, mediating a closed (inactive) active site. In contrast, five of the six ASD-associated mutations showed localized destabilization that contribute to the partial opening of the active site. Our results lend insight into distinctive structural effects of germline PTEN mutations associated with PTEN-ASD vs. those associated with PTEN-cancer, potentially aiding in identification of the shared and separate molecular features that contribute to autism or cancer, thus, providing a deeper understanding of genotype-phenotype relationships for germline PTEN mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Butler, M. G., Dasouki, M. J., Zhou, X.-P., Talebizadeh, Z., Brown, M., Takahashi, T. N., Miles, J. H., Wang, C. H., Stratton, R., Pilarski, R., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024646 · Cited by 778 · cited 1×
“Germline PTEN mutations are present in 10–20% of children with ASD accompanied by macrocephaly (Butler et al., 2005; McBride et al., 2010; Tan et al., 2011).”
BackgroundSelf-citationWu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Marsh, D. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.507 · Cited by 653 · cited 2×
“Previous studies using in vivo- and in vitro-based methods have also elucidated concentration of germline PTEN mutations in the phosphatase domain (Han et al., 2000; Lee et al., 1999; Marsh et al., 1998; Mester & Eng, 2013; Rodriguez-Escudero et al., 2011).”
BackgroundThe genetics of autistic disorders and its clinical relevance: a review of the literature
Freitag, C. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001896 · Cited by 638 · cited 1×
“ASD is a relatively common, highly heritable neurodevelopmental disorder that is characterized by social impairment and restricted, repetitive behavior (Frazier et al., 2012; Freitag, 2007).”
BackgroundProtean PTEN: Form and Function
Waite, K. A., & Eng, C. (2002) · The American Journal of Human Genetics · doi:10.1086/340026 · Cited by 457 · cited 2×
“In fact, studies from our lab (Waite & Eng, 2002) and others (Han et al., 2000; Maehama et al., 2001; Rodriguez-Escudero et al., 2011) indicate that mutations within the active site pocket lead to a loss of PTEN phosphatase activity.”
BackgroundSelf-citationValidation of Proposed DSM-5 Criteria for Autism Spectrum Disorder
Frazier, T. W., Youngstrom, E. A., Speer, L., Embacher, R., Law, P., Constantino, J., Findling, R. L., Hardan, A. Y., & Eng, C. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.09.021 · Cited by 392 · cited 1×
“ASD is a relatively common, highly heritable neurodevelopmental disorder that is characterized by social impairment and restricted, repetitive behavior (Frazier et al., 2012; Freitag, 2007).”
BackgroundSelf-citationFrazier, T. W., Embacher, R., Tilot, A. K., Koenig, K., Mester, J., & Eng, C. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.125 · Cited by 177 · cited 2×
“…center reveal an enrichment of germline PTEN mutations of the missense type in patients with ASD with macrocephaly compared to PHTS patients without ASD, however, an absolute genotype–phenotype correlation still remains unidentifiable (Frazier et al., 2015; He et al., 2013; Leslie & Longy, 2016).”
BackgroundSelf-citation
Cited by
PremPS: Predicting the impact of missense mutations on protein stability
Chen, Y., Lu, H., Zhang, N., Zhu, Z., Wang, S., & Li, M. (2020) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1008543 · Cited by 260
The Clinical Spectrum of PTEN Mutations
Yehia, L., Keel, E., & Eng, C. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-052218-125823 · Cited by 253
Self-citationAllostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Nussinov, R., Zhang, M., Maloney, R., Liu, Y., Tsai, C.-J., & Jang, H. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167569 · Cited by 66
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
Serebriiskii, I. G., Pavlov, V., Tricarico, R., Andrianov, G., Nicolas, E., Parker, M. I., Newberg, J., Frampton, G., Meyer, J. E., & Golemis, E. A. (2022) · Nature Communications · doi:10.1038/s41467-022-29227-2 · Cited by 55
Bucher, M., Niebling, S., Han, Y., Molodenskiy, D., Hassani Nia, F., Kreienkamp, H.-J., Svergun, D., Kim, E., Kostyukova, A. S., Kreutz, M. R., et al. (2021) · eLife · doi:10.7554/elife.66165 · Cited by 33
“Bioinformatics studies suggested that functional consequences of missense mutations can be predicted based on structural features for the ASD- and cancer-associated protein phosphatase PTEN, as well as for voltage-gated sodium and calcium channels (Heyne et al., 2020; Smith et al., 2019a; Smith et al., 2019b).”
Background
Metadata
- Authors
- Smith, I. N., Thacker, S., Jaini, R., & Eng, C.
- Venue
- Journal of Biomolecular Structure and Dynamics
- Publisher
- Informa UK Limited
- Published
- 2018-05-14
- Volume
- 37
- Issue
- 7
- Pages
- 1766-1782
- ISSN
- 0739-1102 (ISSN-L)
- 1538-0254
- OpenAlex
- W2799521326
- Cited by
- 46
- References
- 7
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.